SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 42.02 |
Enterprise Value ($M) | 41.36 |
Book Value ($M) | 3.41 |
Book Value / Share | 0.12 |
Price / Book | 12.31 |
NCAV ($M) | 3.30 |
NCAV / Share | 0.11 |
Price / NCAV | 12.74 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.72 |
Return on Assets (ROA) | -0.77 |
Return on Equity (ROE) | -1.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.15 |
Current Ratio | 5.15 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.69 |
Assets | 10.81 |
Liabilities | 7.39 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Francisco Trust under agreement dated February 28, 1996 | 11.52 | -3.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
34,177 | 79,123 | 43.19 | |
1,147 | 11,331 | 10.12 | |
510 | 9,227 | 5.53 | |
10,154 | 12,937 | 78.49 | |
12,059 | 25,897 | 46.57 | |
(click for more detail) |
Similar Companies | |
---|---|
DRUG – Bright Minds Biosciences Inc. | DTIL – Precision BioSciences, Inc. |
DWTX – Dogwood Therapeutics, Inc. | EDSA – Edesa Biotech, Inc. |
ELDN – Eledon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io